Aa
A
A
A
Close
HIV - Prevention Forum
This expert forum is not accepting new questions. Please post your question in one of our medical support communities.
Avatar universal

Negative PCR

Hello-

I am a resident. On July 7th of this year I was performing an invasive procedure and was not wearing eye protection. A drop or two of serosanguinous fluid from a known HIV+ patient (class 2) got into my left eye.

I started Combivir at 5 hrs post exposure and continued for 28 days. My baseline, 2 wk and 6 wk ELISA's have been negative. Despite knowing the recommendations, especially after PEP, I was preoccupied enough with the idea of transmission that I recently got a DNA PCR- at about 7-8 weeks post exposure; 3-4 wks after completion of PEP. It was negative.

Based on the literature and your personal opinion, what do you think the risk of me seroconverting is at 3 mo, 6 mo, or year? Have there been cases of seroconversion despite negative PCR 1 mo after completion of PEP?

Thank you. I appreciate your advice.

Resident
2 Responses
239123 tn?1267651214
MEDICAL PROFESSIONAL
Welcome to the forum.

I assume (and certainly hope) you discussed this exposure event with the hospital or clinic infection control team, and that an ID specialist or other HIV/AIDS expert prescribed your PEP regimen and is following you.  If so, that person's advice is just as valid as ours on this forum, perhaps more so.  Dr. Hook and I have little direct experience in prescribing PEP and in following people after known HIV exposures.

That said, you had a low risk exposure.  Conjunctival exposure to HIV infected secretions is one of those listed risk factors, based on common sense and general knowledge of HIV transmission mechanisms, with few known cases of transmission.  I am unaware of any case reports of documented transmission by this route.  Also, what is the infectiousness status of the source patient?  "Stage 2" isn't helpful; the important information is his or her viral load and whether s/he is on antiretroviral therapy.  If the viral load is low, and especially if it is undetectable on ART, then there probably was no transmission risk at all.

Your immediate questions about test reliability and timing get to the issue of whether, when PEP doesn't work, seroconversion time or time to detection of HIV DNA, are delayed and by how much.  To my knowledge, there are no data, only common sense assumptions by knowledgeable experts.  However, most experts believe seroconversion still would occur within a month of stopping PEP; and that PCR would be positive within 7-10 days of completing PEP.  I am unaware of any reports otherwise, i.e. of it taking a month after completing PEP for PCR to become positive.  Therefore, it is likely your current test results are 100% reliable.

I'll be interested in further information about the patient's viral load and ART.  But even if not on treatment and high VL, I would judge the chance you have HIV -- in view of the nature of the exposure, plus PEP, plus your current test results -- as zero or close to it.  However, as implied above, you should have asked these questions of your own provider.  If you have not, you definitely should do so; and follow his or her opinions and advice if they differ from mine.

Best wishes for your continuing medical training and a successful career.

HHH, MD
Avatar universal
Thank you for your input,
The patient's viral load was 40K and he was on Kaletra at the time. Before starting Kaletra about 8 months prior, his viral load was about 120K.

Resident
Didn't find the answer you were looking for?
Ask a question
Popular Resources
These tips can help HIV-positive women live a long, healthy life.
Despite the drop in new infections, black women are still at a high risk for HIV, the virus that causes Aids.
What are your HIV treatment options, and how do you choose the right one? Our panel of experts weighs in.
Learn the truth behind 14 common misconceptions about HIV.
Can HIV be transmitted through this sexual activity? Dr. Jose Gonzalez-Garcia answers this commonly-asked question.
A breakthrough study discovers how to reduce risk of HIV transmission by 95 percent.